Imunon, Inc. (IMNN)
3.27
-0.15
(-4.39%)
USD |
NASDAQ |
Feb 12, 16:00
3.29
+0.02
(+0.61%)
After-Hours: 06:05
Imunon Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cellectar Biosciences, Inc. | 0.00 |
| PDS Biotechnology Corp. | 0.00 |
| PAVmed, Inc. | -0.003M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.441M |
| Cash from Financing (Quarterly) | 4.963M |
| Free Cash Flow | -14.95M |
| Free Cash Flow Per Share (Quarterly) | -1.509 |
| Free Cash Flow to Equity (Quarterly) | -4.350M |
| Free Cash Flow to Firm (Quarterly) | -4.441M |
| Free Cash Flow Yield | -54.64% |